ExpressPoints: Key Studies in Breast and Gynecologic Cancers

Domenica Lorusso, MD, PhD, on the molecular reclassification of endometrial cancers and key ongoing immunotherapy trials, from Clinical Care Options (CCO)

Domenica Lorusso, MD, PhD Released: February 25, 2021

From Clinical Care Options (CCO), Webcast and downloadable slides reviewing the latest data on the use of PARP inhibitors to treat newly diagnosed advanced ovarian cancer

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci
Program Director Alexandra Leary, MD, PhD Frederik Marmé, MD, PhD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: February 19, 2021 Expired: February 18, 2022

Expert review and discussion of key data from SABCS 2020 in HER2-positive and hormone receptor–positive/HER2-negative disease, and metastatic triple-negative breast cancer from Clinical Care Options (CCO)

Sara Hurvitz, MD, FACP Joyce O'Shaughnessy, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: February 19, 2021 Expired: February 18, 2022

On-demand Clinical Care Options (CCO) Webcast that reviews the latest clinical data informing the optimal management of patients with ovarian cancer from an expert global perspective.

Antonio Gonzalez-Martin, MD, PhD Ursula Matulonis, MD Prof Ignace Vergote Released: February 11, 2021